Poland· PL-100447560
Prenessa
A perindopril product containing tert-butylamini perindoprilum, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 15 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Perindopril is registered in 15 of 19 countries.
Countries holding a registration under ATC C09AA04 (perindopril), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 10 of them publish a price we can compare per daily dose
Perindopril · ATC C09AA04
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
Price per daily dose
What a daily dose of perindopril costs, country by country.
Normalised to the WHO defined daily dose (4 mg), the median price runs from $0.11 in France to $0.44 in Switzerland — a ×4.0 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Perindopril · price per daily dose (4 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.44
- IT Italy$0.22
- ES Spain$0.20
- FR France$0.11
The record
At a glance
URPL (Poland)- Active substance
- tert-Butylamini perindoprilum
- Manufacturer
- InPharm Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- C09AA04
- ATC class
- Perindopril
- Defined daily dose
- 4 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991448066
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
356 interactions on record for perindopril.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Perindopril · interactions on record
356 records
- 11 severe
- 165 moderate
- 18 minor
- 87 info
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium gluconateA12BA05severe
- Potassium chlorideB05XA01severe
75 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ea0b68e4-178a-411f-b0aa-da36ba50c23c GET /v1/drugs/ea0b68e4-178a-411f-b0aa-da36ba50c23c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "4 mg",
"packaging": "05909991448066 ¦ Rp ¦ 139214\n30 tabl.",
"substance": "tert-Butylamini perindoprilum 4 mg",
"common_name": "tert-Butylamini perindoprilum",
"pl_product_id": "100447560",
"pozwolenie_nr": "56/21",
"auth_procedure": "IR",
"authorisation_validity": "2026-02-15"
}See everything about perindopril.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.